CSF2 and neoplasm: Cancer vaccines stimulate the immune system to recognize and attack PCa cells and sipuleucel-T (Provenge, a dendritic cell vaccine pulsed with a chimeric protein expressing GM-CSF and PAP as a tumor-associated antigen) is the most common vaccine used for PCa.